Tyrosines 559 and 807 in the cytoplasmic tail of the macrophage colony-stimulating factor receptor play distinct roles in osteoclast differentiation and function - PubMed (original) (raw)
. 2002 Dec;143(12):4868-74.
doi: 10.1210/en.2002-220467.
Affiliations
- PMID: 12446614
- DOI: 10.1210/en.2002-220467
Tyrosines 559 and 807 in the cytoplasmic tail of the macrophage colony-stimulating factor receptor play distinct roles in osteoclast differentiation and function
Xu Feng et al. Endocrinology. 2002 Dec.
Abstract
Osteoclast (OC) differentiation requires that precursors, such as macrophage colony-stimulating factor (M-CSF)-dependent bone marrow macrophages, receive signals transduced by receptor activator of nuclear factor kappaB (RANK) and c-Fms, receptors for RANK ligand (RANKL) and M-CSF, respectively. Activated c-Fms autophosphorylates cytoplasmic tail tyrosine residues, which, by recruiting adaptor molecules, initiate specific signaling pathways. To identify which tyrosine residues are involved in c-Fms signaling in primary cells, we retrovirally transduced M-CSF-dependent bone marrow macrophages with a chimera comprising the external domain of the erythropoietin (Epo) receptor linked to the transmembrane and cytoplasmic domains of c-Fms. Transduced cells differentiate into bone-resorbing osteoclasts when treated with RANKL and either M-CSF or Epo, confirming that both endogenous and chimeric receptors transmit osteoclastogenic signals. Cells expressing chimeric receptors with Y(697)F, Y(706)F, Y(721)F, and Y(921)F single point mutations generate normal numbers of bone-resorbing OCs, with normal bone-resorbing activity when treated with RANKL and Epo. In contrast, those expressing Y(559)F generate fewer OCs, whereas theY807F mutant is incapable of osteoclastogenesis. Finally, although mature OCs expressing Y(559)F exhibit impaired bone resorption, those bearing Y807F do not. Thus, we have identified specific tyrosine residues in the cytoplasmic tail of c-Fms that are critical for transmitting M-CSF-initiated signals individually required for OC formation or function, respectively.
Similar articles
- c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation.
Faccio R, Takeshita S, Zallone A, Ross FP, Teitelbaum SL. Faccio R, et al. J Clin Invest. 2003 Mar;111(5):749-58. doi: 10.1172/JCI16924. J Clin Invest. 2003. PMID: 12618529 Free PMC article. - Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N. Itoh K, et al. Endocrinology. 2001 Aug;142(8):3656-62. doi: 10.1210/endo.142.8.8300. Endocrinology. 2001. PMID: 11459815 - alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology.
Ross FP, Teitelbaum SL. Ross FP, et al. Immunol Rev. 2005 Dec;208:88-105. doi: 10.1111/j.0105-2896.2005.00331.x. Immunol Rev. 2005. PMID: 16313343 Review. - Growth and differentiation signals regulated by the M-CSF receptor.
Rohrschneider LR, Bourette RP, Lioubin MN, Algate PA, Myles GM, Carlberg K. Rohrschneider LR, et al. Mol Reprod Dev. 1997 Jan;46(1):96-103. doi: 10.1002/(SICI)1098-2795(199701)46:1<96::AID-MRD15>3.0.CO;2-1. Mol Reprod Dev. 1997. PMID: 8981370 Review.
Cited by
- The M-CSF receptor in osteoclasts and beyond.
Mun SH, Park PSU, Park-Min KH. Mun SH, et al. Exp Mol Med. 2020 Aug;52(8):1239-1254. doi: 10.1038/s12276-020-0484-z. Epub 2020 Aug 17. Exp Mol Med. 2020. PMID: 32801364 Free PMC article. Review. - Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis.
Park H, Ishihara D, Cox D. Park H, et al. Arch Biochem Biophys. 2011 Jun 15;510(2):101-11. doi: 10.1016/j.abb.2011.02.019. Epub 2011 Feb 26. Arch Biochem Biophys. 2011. PMID: 21356194 Free PMC article. Review. - A ERK/RSK-mediated negative feedback loop regulates M-CSF-evoked PI3K/AKT activation in macrophages.
Wang L, Iorio C, Yan K, Yang H, Takeshita S, Kang S, Neel BG, Yang W. Wang L, et al. FASEB J. 2018 Feb;32(2):875-887. doi: 10.1096/fj.201700672RR. Epub 2018 Jan 4. FASEB J. 2018. PMID: 29046360 Free PMC article. - Osteoclasts: what do they do and how do they do it?
Teitelbaum SL. Teitelbaum SL. Am J Pathol. 2007 Feb;170(2):427-35. doi: 10.2353/ajpath.2007.060834. Am J Pathol. 2007. PMID: 17255310 Free PMC article. - Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging.
Jeffery JJ, Lux K, Vogel JS, Herrera WD, Greco S, Woo HH, AbuShahin N, Pagel MD, Chambers SK. Jeffery JJ, et al. Exp Biol Med (Maywood). 2014 Apr;239(4):404-13. doi: 10.1177/1535370214522588. Epub 2014 Mar 5. Exp Biol Med (Maywood). 2014. PMID: 24599884 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AR-32788/AR/NIAMS NIH HHS/United States
- AR-42404/AR/NIAMS NIH HHS/United States
- AR-45623/AR/NIAMS NIH HHS/United States
- AR-46582/AR/NIAMS NIH HHS/United States
- DE-05413/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous